Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-30
Closed -$7.25K 79
2023
Q1
$7.25K Buy
+30
New +$7.36K 0.02% 69
2022
Q4
Sell
-26
Closed -$6K 93
2022
Q3
$6K Buy
26
+1
+4% +$242 ﹤0.01% 101
2022
Q2
$6K Sell
25
-1
-4% -$245 ﹤0.01% 128
2022
Q1
$6K Hold
26
﹤0.01% 131
2021
Q4
$6K Sell
26
-40
-61% -$8.44K ﹤0.01% 119
2021
Q3
$14K Buy
66
+40
+154% +$9.21K ﹤0.01% 88
2021
Q2
$6K Sell
26
-1
-4% -$246 ﹤0.01% 147
2021
Q1
$7K Sell
27
-8
-23% -$1.91K ﹤0.01% 92
2020
Q4
$8K Buy
+35
New +$8.07K ﹤0.01% 98
2019
Q2
Sell
-150
Closed -$28K 151
2019
Q1
$28K Sell
150
-150
-50% -$28.6K 0.06% 107
2018
Q4
$58K Buy
+300
New +$58.5K 0.01% 64

Other funds holding AMGN

Mizuho Securities's AMGN Position: Q2 2023 in Review

Mizuho Securities sold out of Amgen (AMGN) in Q2 2023, closing a stake of 30 shares — an estimated $7.25K sold.

Mizuho Securities first reported a position in AMGN in Q4 2018 and held it in 11 quarters. The position peaked at $58K in Q4 2018. 2,390 funds tracked by Wall St. Rank hold AMGN as of Q2 2023.

  • Mizuho Securities reported no remaining Amgen position as of Q2 2023 after selling out during the quarter.
  • Mizuho Securities sold 30 Amgen shares in Q2 2023, an estimated $7.25K.
  • Mizuho Securities first reported a position in Amgen in Q4 2018 and held it in 11 quarters.
  • Mizuho Securities's Amgen position peaked at $58K in Q4 2018.
  • 2,390 funds tracked by Wall St. Rank held Amgen as of Q2 2023.

Based on Mizuho Securities's 13F filing for Q2 2023, filed 1 Aug 2023.